Pitolisant: Pediatric First Approval.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 4, p. 483, doi. 10.1007/s40272-023-00575-w
- By:
- Publication type:
- Article
Works matching IS 11745878 AND DT 2023 AND VI 25 AND IP 4
Results: 9
1
2
Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES Survey.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 4, p. 459, doi. 10.1007/s40272-023-00574-x
- By:
- Publication type:
- Article
3
Macitentan in the Young—Mid-term Outcomes of Patients with Pulmonary Hypertensive Vascular Disease treated in a Pediatric Tertiary Care Center.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 4, p. 467, doi. 10.1007/s40272-023-00573-y
- By:
- Publication type:
- Article
4
Pharmacokinetics in Critically Ill Children with Acute Kidney Injury.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 4, p. 425, doi. 10.1007/s40272-023-00572-z
- By:
- Publication type:
- Article
5
Cardiac Hypertrophy Associated with Insulin Therapy in Extremely Preterm Infants.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 4, p. 453, doi. 10.1007/s40272-023-00571-0
- By:
- Publication type:
- Article
6
Pediatric Status Epilepticus: Treat Early and Avoid Delays.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 4, p. 411, doi. 10.1007/s40272-023-00570-1
- By:
- Publication type:
- Article
7
Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 4, p. 399, doi. 10.1007/s40272-023-00569-8
- By:
- Publication type:
- Article
8
Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 4, p. 389, doi. 10.1007/s40272-023-00568-9
- By:
- Publication type:
- Article
9
Thromboprophylaxis for Coagulopathy Related to COVID-19 in Pediatrics: A Narrative Review.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 4, p. 443, doi. 10.1007/s40272-023-00566-x
- By:
- Publication type:
- Article